The Danish National Genome Center

Develops and operates a national infrastructure for personalised medicine, including infrastructure for whole genome sequencing and a supercomputer system for data analysis and storing the information in a national genome database.

DNGC develops and operates a national infrastructure for personalised medicine, including infrastructure for whole genome sequencing and a supercomputer system for data analysis and storing the information in a national genome database. All data from whole genome sequencing performed in the healthcare system must be reported to the national genome database, ensuring the accumulation of genomic data over time. This data will be accessible for clinicians and researchers for use in patient treatment and research projects.

DNGC represents Denmark in the European 1+ Million Genome Initiative. The aim of the initiative is to give Danish researchers and clinicians the opportunity to gain access to genomic data across borders and benefit from genetics-based diagnostics and treatment knowledge in Europe. The DNCG also engages in formalised bilateral collaborations with Sweden and France.

DNGC was established on 1 May 2019 as a government agency under the Ministry of Health, as part of the National Strategy for Personalised Medicine (2017-2020). DNGC is financed by the Danish state and the Novo Nordisk Foundation.